Early phase development of PI3kinase inhibitors for anticancer therapies.

Saved in:
Bibliographic Details
Title: Early phase development of PI3kinase inhibitors for anticancer therapies.
Authors: Caputo C; Laboratory of Molecular and Precision Oncology, Institute of Genetic Research, Biogem Scarl, Ariano Irpino, Italy.; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Lombardi A; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Department of Theoretical and Applied Sciences, eCampus University, Novedrate, Italy., Vicario M; Laboratory of Molecular and Precision Oncology, Institute of Genetic Research, Biogem Scarl, Ariano Irpino, Italy., Cautela D; Department of Theoretical and Applied Sciences, eCampus University, Novedrate, Italy., Addeo R; Division of Oncology, Hospital of Frattamaggiore 'S. Giovanni di Dio', Frattaminore (NA), Italy., Melisi F; Laboratory of Molecular and Precision Oncology, Institute of Genetic Research, Biogem Scarl, Ariano Irpino, Italy., Grimaldi A; U.P. Cytometric and Mutational Diagnostics, Vanvitelli Hospital, University of Campania 'Luigi Vanvitelli', Naples, Italy., Necas A; CEITEC - Central European Institute of Technology, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czechia., Amler E; Department of Biophysics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic., Sperlongano R; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Caraglia M; Laboratory of Molecular and Precision Oncology, Institute of Genetic Research, Biogem Scarl, Ariano Irpino, Italy.; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Nov; Vol. 34 (11), pp. 905-920. Date of Electronic Publication: 2025 Nov 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7658
DOI:10.1080/13543784.2025.2582080